Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Kidney/Renal Fibrosis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Kidney/Renal Fibrosis Treatmentmarket, defines the market attractiveness level of Kidney/Renal Fibrosis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Kidney/Renal Fibrosis Treatment industry, describes the types of Kidney/Renal Fibrosis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Kidney/Renal Fibrosis Treatment market and the development prospects and opportunities of Kidney/Renal Fibrosis Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Kidney/Renal Fibrosis Treatment market in Chapter 13.
By Player:
InterMune Inc
F Hoffman-La Roche Ltd
La Jolla Pharmaceutical Company
BioLine Rx Ltd
ProMetic Life-Sciences Inc
Merck & Co
Galectin Therapeutics
Pfizer Inc
Genzyme Corporation
By Type:
Angiotensin II Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors
By End-User:
Commercial/Private Hospitals
Public Health Hospitals
Clinics
Home Treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Kidney/Renal Fibrosis Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Kidney/Renal Fibrosis Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Kidney/Renal Fibrosis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Kidney/Renal Fibrosis Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Kidney/Renal Fibrosis Treatment Market Analysis and Outlook to 2022
-
7.1 Global Kidney/Renal Fibrosis Treatment Consumption (2017-2022)
-
7.2 United States Kidney/Renal Fibrosis Treatment Consumption (2017-2022)
-
7.3 Europe Kidney/Renal Fibrosis Treatment Consumption (2017-2022)
-
7.4 China Kidney/Renal Fibrosis Treatment Consumption (2017-2022)
-
7.5 Japan Kidney/Renal Fibrosis Treatment Consumption (2017-2022)
-
7.6 India Kidney/Renal Fibrosis Treatment Consumption (2017-2022)
-
7.7 South Korea Kidney/Renal Fibrosis Treatment Consumption (2017-2022)
8 Region and Country-wise Kidney/Renal Fibrosis Treatment Market Analysis and Outlook to 2028
-
8.1 Global Kidney/Renal Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.2 United States Kidney/Renal Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Kidney/Renal Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.4 China Kidney/Renal Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Kidney/Renal Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.6 India Kidney/Renal Fibrosis Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Kidney/Renal Fibrosis Treatment Consumption Forecast (2022-2028)
9 Global Kidney/Renal Fibrosis Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney/Renal Fibrosis Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Angiotensin II Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pirfenidone Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Vasopeptidase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney/Renal Fibrosis Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Commercial/Private Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Public Health Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Home Treatment Consumption and Growth Rate (2017-2022)
10 Global Kidney/Renal Fibrosis Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Angiotensin II Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Vasopeptidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Commercial/Private Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Public Health Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Home Treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Kidney/Renal Fibrosis Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Kidney/Renal Fibrosis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Kidney/Renal Fibrosis Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Kidney/Renal Fibrosis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Kidney/Renal Fibrosis Treatment Market Competitive Analysis
-
14.1 InterMune Inc
-
14.1.1 InterMune Inc Company Details
-
14.1.2 InterMune Inc Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 InterMune Inc Kidney/Renal Fibrosis Treatment Product and Service
-
14.2 F Hoffman-La Roche Ltd
-
14.2.1 F Hoffman-La Roche Ltd Company Details
-
14.2.2 F Hoffman-La Roche Ltd Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 F Hoffman-La Roche Ltd Kidney/Renal Fibrosis Treatment Product and Service
-
14.3 La Jolla Pharmaceutical Company
-
14.3.1 La Jolla Pharmaceutical Company Company Details
-
14.3.2 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Product and Service
-
14.4 BioLine Rx Ltd
-
14.4.1 BioLine Rx Ltd Company Details
-
14.4.2 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Product and Service
-
14.5 ProMetic Life-Sciences Inc
-
14.5.1 ProMetic Life-Sciences Inc Company Details
-
14.5.2 ProMetic Life-Sciences Inc Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ProMetic Life-Sciences Inc Kidney/Renal Fibrosis Treatment Product and Service
-
14.6 Merck & Co
-
14.6.1 Merck & Co Company Details
-
14.6.2 Merck & Co Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Merck & Co Kidney/Renal Fibrosis Treatment Product and Service
-
14.7 Galectin Therapeutics
-
14.7.1 Galectin Therapeutics Company Details
-
14.7.2 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Product and Service
-
14.8 Pfizer Inc
-
14.8.1 Pfizer Inc Company Details
-
14.8.2 Pfizer Inc Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Inc Kidney/Renal Fibrosis Treatment Product and Service
-
14.9 Genzyme Corporation
-
14.9.1 Genzyme Corporation Company Details
-
14.9.2 Genzyme Corporation Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Kidney/Renal Fibrosis Treatment
-
Figure Kidney/Renal Fibrosis Treatment Picture
-
Table Global Kidney/Renal Fibrosis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney/Renal Fibrosis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Kidney/Renal Fibrosis Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Kidney/Renal Fibrosis Treatment Consumption by Country (2017-2022)
-
Figure United States Kidney/Renal Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney/Renal Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Kidney/Renal Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney/Renal Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Kidney/Renal Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney/Renal Fibrosis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney/Renal Fibrosis Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney/Renal Fibrosis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin II Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Pirfenidone Consumption and Growth Rate (2017-2022)
-
Figure Global Renin Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Vasopeptidase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Commercial/Private Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Public Health Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Home Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin II Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pirfenidone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Renin Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasopeptidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Commercial/Private Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Public Health Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Kidney/Renal Fibrosis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Kidney/Renal Fibrosis Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table InterMune Inc (Foundation Year, Company Profile and etc.)
-
Table InterMune Inc Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table InterMune Inc Kidney/Renal Fibrosis Treatment Product and Service
-
Table F Hoffman-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffman-La Roche Ltd Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman-La Roche Ltd Kidney/Renal Fibrosis Treatment Product and Service
-
Table La Jolla Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Product and Service
-
Table BioLine Rx Ltd (Foundation Year, Company Profile and etc.)
-
Table BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Product and Service
-
Table ProMetic Life-Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table ProMetic Life-Sciences Inc Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table ProMetic Life-Sciences Inc Kidney/Renal Fibrosis Treatment Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Kidney/Renal Fibrosis Treatment Product and Service
-
Table Galectin Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Galectin Therapeutics Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Galectin Therapeutics Kidney/Renal Fibrosis Treatment Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Kidney/Renal Fibrosis Treatment Product and Service
-
Table Genzyme Corporation (Foundation Year, Company Profile and etc.)
-
Table Genzyme Corporation Kidney/Renal Fibrosis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corporation Kidney/Renal Fibrosis Treatment Product and Service
-
